会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Plasmid-encoded neurotoxin genes in Clostridium botulinum serotype A subtypes
    • 肉毒毒素肉毒杆菌血清型A亚型中的质粒编码的神经毒素基因
    • US08435759B2
    • 2013-05-07
    • US12664800
    • 2008-06-27
    • Eric A. JohnsonKristin M. MarshallSabine PellettMarite Bradshaw
    • Eric A. JohnsonKristin M. MarshallSabine PellettMarite Bradshaw
    • C12P21/00C12N15/74
    • C12N9/52C07K14/33C12N15/74C12Y304/24069
    • The present invention provides a novel isolated plasmid, wherein the plasmid is a native plasmid found in unique C. botulinum type A strains and encode either BoNT/A3 or BoNT/A4 and BoNT/B. The present invention also provides a method of obtaining a plasmid-encoded botulinum neurotoxin and botulinum neurotoxin complex comprising the step of isolating a plasmid encoding the cntA/A or cntA/B neurotoxin gene and genes encoding protein components of the toxin complex from a C. botulinum type A strain. The inventors performed comparative analyzes of representative BoNT/A subtype strains by pulsed-field gel electrophoresis (PFGE) and Southern hybridizations with probes specific for the BoNT/A and B genes, cntA/A and cntA/B. Unexpectedly, the inventors determined that the genes encoding BoNT/A3 in the A3 strain, and BoNT/A4 and BoNT/B in the A4 strain, are on plasmids.
    • 本发明提供了一种新的分离质粒,其中质粒是在独特的A型肉毒杆菌中发现的天然质粒,并且编码BoNT / A3或BoNT / A4和BoNT / B。 本发明还提供了获得质粒编码的肉毒杆菌神经毒素和肉毒杆菌神经毒素复合物的方法,包括分离编码cntA / A或cntA / B神经毒素基因的质粒和编码来自C的毒素复合物的蛋白质组分的基因的步骤。 A型肉毒杆菌。 本发明人通过脉冲场凝胶电泳(PFGE)和针对BoNT / A和B基因cntA / A和cntA / B特异性探针的Southern杂交进行了代表性的BoNT / A亚型菌株的比较分析。 出人意料的是,本发明人确定了A3菌株中编码BoNT / A3的基因以及A4菌株中的BoNT / A4和BoNT / B在质粒上。
    • 4. 发明申请
    • CONJUGATIVE PLASMIDS AND METHODS OF USE THEREOF
    • 结合剂及其使用方法
    • US20110171734A1
    • 2011-07-14
    • US12905592
    • 2010-10-15
    • Eric A. JohnsonKristin M. MarshallMarite Bradshaw
    • Eric A. JohnsonKristin M. MarshallMarite Bradshaw
    • C12N15/74C12N15/63
    • C12N15/74
    • The present invention provides novel C. botulinum conjugatively transmissible plasmids and methods of use thereof. Specifically, described herein are novel, conjugatively transmissible clostridial plasmids which are capable of being transferred among and between clostridial species. The novel plasmids of the present invention therefore permits the delivery of heterologous clostridial genes into a clostridial host, such as C. botulinum, and the expression of genes of interest in that host, including clostridial toxins and the nontoxigenic components of the toxin complex, toxin fragments, or antigenic portions thereof, in a way both that ensures abundant expression and facilitates purification. Furthermore, toxins with altered structures, chimeric, hybrid toxins, and other toxin derivatives valuable in medicine could be synthesized in this system.
    • 本发明提供了新型肉毒杆菌共轭传递质粒及其使用方法。 具体地,本文描述的是能够在梭菌之间和之间转移的新颖的,共轭传播的梭菌质粒。 因此,本发明的新型质粒允许将异源梭菌基因递送至梭菌宿主,例如肉毒杆菌,以及该宿主中感兴趣的基因的表达,包括梭菌毒素和毒素复合物的无毒成分,毒素 片段或其抗原部分,以确保丰富的表达并促进纯化的方式。 此外,在该系统中可以合成具有改变的结构的毒素,嵌合型,杂合毒素和在医学中有价值的其它毒素衍生物。
    • 8. 发明申请
    • Method of Preparing Botulinum Neurotoxin Type E Light Chain
    • 肉毒杆菌神经毒素E型轻链的制备方法
    • US20090182123A1
    • 2009-07-16
    • US12273157
    • 2008-11-18
    • Eric A. JohnsonMarite BradshawMichael BaldwinJoseph T. Barbieri
    • Eric A. JohnsonMarite BradshawMichael BaldwinJoseph T. Barbieri
    • C07K14/33
    • C07K14/33
    • The present invention provides a preparation of botulinum toxin light chain type A or E, wherein the preparation is both catalytically active and soluble. Preferably, the preparation consists essentially of amino acid residues 1 through 425 of the botulinum toxin light chain type A. A method of screening inhibitors is also provided, wherein the method comprises exposing a test inhibitor to the preparation of botulinum toxin light chain type A and evaluating the biological activity of the preparation. In another embodiment, a method of providing a catalytically active, soluble preparation of botulinum toxin light chain, type A is provided, wherein the method comprises obtaining an expression vector comprising a DNA sequence encoding amino acid residues 1-425 and expressing a polypeptide.
    • 本发明提供了A型或E型轻链型肉毒杆菌毒素的制备方法,其中所述制剂既具有催化活性,又具有可溶性。 优选地,制剂基本上由A型肉毒毒素轻链的氨基酸残基1至425组成。还提供了筛选抑制剂的方法,其中所述方法包括将测试抑制剂暴露于A型轻链A型肉毒杆菌毒素的制备中, 评估制剂的生物活性。 在另一个实施方案中,提供了提供A型肉毒毒素轻链的催化活性可溶性制剂的方法,其中所述方法包括获得包含编码氨基酸残基1-425的DNA序列并表达多肽的表达载体。
    • 9. 发明授权
    • Method of preparing botulinum neurotoxin type E light chain
    • 制备肉毒杆菌神经毒素E型轻链的方法
    • US07833524B2
    • 2010-11-16
    • US12273157
    • 2008-11-18
    • Eric A. JohnsonMarite BradshawMichael BaldwinJoseph T. Barbieri
    • Eric A. JohnsonMarite BradshawMichael BaldwinJoseph T. Barbieri
    • C12P1/04
    • C07K14/33
    • The present invention provides a preparation of botulinum toxin light chain type A or E, wherein the preparation is both catalytically active and soluble. Preferably, the preparation consists essentially of amino acid residues 1 through 425 of the botulinum toxin light chain type A. A method of screening inhibitors is also provided, wherein the method comprises exposing a test inhibitor to the preparation of botulinum toxin light chain type A and evaluating the biological activity of the preparation. In another embodiment, a method of providing a catalytically active, soluble preparation of botulinum toxin light chain, type A is provided, wherein the method comprises obtaining an expression vector comprising a DNA sequence encoding amino acid residues 1-425 and expressing a polypeptide.
    • 本发明提供了A型或E型轻链型肉毒杆菌毒素的制备方法,其中所述制剂既具有催化活性,又具有可溶性。 优选地,制剂基本上由A型肉毒毒素轻链的氨基酸残基1至425组成。还提供了筛选抑制剂的方法,其中所述方法包括将测试抑制剂暴露于A型轻链A型肉毒杆菌毒素的制备 评估制剂的生物活性。 在另一个实施方案中,提供了提供A型肉毒毒素轻链的催化活性可溶性制剂的方法,其中所述方法包括获得包含编码氨基酸残基1-425的DNA序列并表达多肽的表达载体。